PND6 COST-EFFECTIVENESS OF GLATIRAMER ACETATE AND NATALIZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE PRESENCE OF LONG-TERM CLINICAL EVIDENCE
JB Graham, SR Earnshaw, J Castelli-Haley, M Oleen-Burkey, KP JohnsonVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65344-2
File:
PDF, 72 KB
english, 2007